ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,631Medicare Part D Prescriptions Filled, Including Refills

Rank: 85 out of 2061

$1.49M Total Retail Price of All Prescriptions

Rank: 32 out of 2061

811 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 811 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 811 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 16,119 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$80 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SIMVASTATIN 684 597 1 1
OMEPRAZOLE 542 460 2 5
FUROSEMIDE 504 453 3 6
HYDROCODONE-ACETAMINOPHEN 500 397 S3 4 10
LEVOTHYROXINE SODIUM 500 428 4 3
AMLODIPINE BESYLATE 492 452 6 4
METOPROLOL TARTRATE 489 454 7 7
SYNTHROID 457 405 8 58
ATORVASTATIN CALCIUM 448 371 9 8
CYMBALTA 317 270 10 59
LISINOPRIL 315 292 11 2
DIOVAN 309 281 12 41
ENALAPRIL MALEATE 304 266 13 75
POTASSIUM CHLORIDE 275 225 14 16
LOSARTAN POTASSIUM 270 244 15 17
GLIMEPIRIDE 264 233 16 33
METFORMIN HCL 254 195 17 9
LANTUS SOLOSTAR 234 226 18 76
CARVEDILOL 226 200 19 22
CITALOPRAM HBR 225 185 20 20
TRAMADOL HCL 207 172 21 18
CRESTOR 193 176 22 31
BYSTOLIC 189 166 23 130
ALLOPURINOL 186 178 24 28
ATENOLOL 176 160 25 13
DIOVAN HCT 176 144 25 99
METOPROLOL SUCCINATE 173 142 27 19
GABAPENTIN 169 122 28 15
PRAVASTATIN SODIUM 166 136 29 14
ISOSORBIDE MONONITRATE ER 163 138 30 42
HYDROCHLOROTHIAZIDE 161 151 31 12
NEXIUM 160 153 32 26
CLOPIDOGREL 152 146 33 29
TRAZODONE HCL 150 114 34 39
OXYCODONE-ACETAMINOPHEN 147 113 S2 35 36
ALENDRONATE SODIUM 140 129 36 25
PREDNISONE 139 123 37 32
WARFARIN SODIUM 134 111 38 11
ZETIA 133 106 39 68
PLAVIX 128 123 40 49
ZOLPIDEM TARTRATE 128 113 40 23
PANTOPRAZOLE SODIUM 126 116 42 45
PEN NEEDLE 126 123 42 116
KLOR-CON M20 121 111 44 47
NOVOLOG FLEXPEN 119 112 45 177
SPIRIVA 116 88 46 63
COUMADIN 108 94 47 218
TAMSULOSIN HCL 106 93 48 30
LANTUS 105 92 49 48
ALPRAZOLAM 102 79 50 85
ADVAIR DISKUS 102 67 50 57
EXFORGE 100 86 52 257
SERTRALINE HCL 100 95 52 21
DIGOXIN 98 85 54 56
ESCITALOPRAM OXALATE 97 83 55 77
MIRTAZAPINE 92 92 56 46
NAMENDA 91 91 57 37
EXELON 90 90 58 94
PROAIR HFA 87 63 59 40
NIFEDIPINE ER 85 80 60 134
TRICOR 85 83 60 128
PRAMIPEXOLE DIHYDROCHLORIDE 79 71 62 249
SPIRONOLACTONE 78 64 63 62
DEXILANT 74 49 64 236
NIFEDICAL XL 70 56 65 259
VENLAFAXINE HCL ER 70 18 65 109
CIPROFLOXACIN HCL 68 61 67 54
LOSARTAN-HYDROCHLOROTHIAZIDE 67 59 68 50
SINGULAIR 67 38 68 88
NIASPAN 65 58 70 155
POLYETHYLENE GLYCOL 3350 64 64 71 64
SYMBICORT 63 47 72 158
LEVOFLOXACIN 61 55 73 111
JANUVIA 61 50 73 51
TORSEMIDE 58 39 75 126
CALCITRIOL 58 58 75 208
PAROXETINE HCL 57 44 77 61
LYRICA 57 38 77 83
BENAZEPRIL HCL 55 55 79 124
AZITHROMYCIN 54 43 80 34
TRIAMTERENE-HCTZ 53 49 81 38
SOTALOL 53 53 81 240
AMIODARONE HCL 53 47 81 168
FLUTICASONE PROPIONATE 53 47 81 43
AMLODIPINE BESYLATE-BENAZEPRIL 52 52 85 79
PRADAXA 52 52 85 227
CELEBREX 52 42 85 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 1, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.